Lantern Pharma Inc. Common Stock
$1.93
Market Cap
$24.67M
Shares Outstanding
12.8M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Jun 11, 2020
Round Lot
100
Locale
US
Day Open
$1.73
Day High
$1.96
Day Low
$1.73
Volume
362.6K
VWAP
$1.86
Prev Close
$1.70
Transactions
--
Acc. Volume
--
Lantern Pharma Inc is a biopharmaceutical company focused on developing oncology drug candidates using its artificial intelligence platform. The company utilizes its proprietary RADR platform to identify, develop, and advance small molecule therapies and antibody-drug conjugates, with a pipeline that includes three lead small molecule drug candidates (LP-300, LP-184, and LP-284) targeting solid tumors and blood cancers. It also advances programs through its subsidiary focused on central nervous system and brain cancers.
Lantern Pharma Inc. Common Stock (LTRN) closed the 2026-09-16 session at $1.93, up 13.53% versus the previous close (+0.23). The stock opened at $1.73 and traded between $1.73 and $1.96 during that session. Session trading volume was 363K shares. The volume-weighted average price (VWAP) is $1.86.
Lantern Pharma Inc is a biopharmaceutical company focused on developing oncology drug candidates using its artificial intelligence platform. The company utilizes its proprietary RADR platform to identify, develop, and advance small molecule therapies and antibody-drug conjugates, with a pipeline that includes three lead small molecule drug candidates (LP-300, LP-184, and LP-284) targeting solid tumors and blood cancers. It also advances programs through its subsidiary focused on central nervous system and brain cancers.
Lantern Pharma Inc. Common Stock has a market capitalization of $24.7 million. The company operates in the PHARMACEUTICAL PREPARATIONS industry classification. LTRN is listed on the XNAS exchange. The company employs approximately 16 people. Lantern Pharma Inc. Common Stock is headquartered in DALLAS, TX. The recorded listing date is 2020-06-11.
On this page you can find market LTRN stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the PHARMACEUTICAL PREPARATIONS sector.